Delivery Order SPE2DR25D1106-SPE2DR26FHY7D
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 19, 2025, for the supply of Trulicity 1.5 mg/0.5 ml pens valued at $8,764.26. This is a firm fixed price, non-competitive delivery order with an ultimate completion date of September 22, 2025, and performance to be executed at AmerisourceBergen's Conshohocken, Pennsylvania facility. The award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $4,878.61 by the Defense Logistics Agency (DLA) on September 18, 2025, with a completion date of September 19, 2025. The contract covers the supply of Trulicity 1.5 mg/0.5 mL pen injectable medication, a diabetes treatment. This is a firm fixed price, competitively awarded delivery order with no set-aside designation, issued under AmerisourceBergen's...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a $1,051.05 firm fixed-price delivery order on June 17, 2025, by the Defense Logistics Agency to supply Trulicity 1.5 mg/0.5 ml pens. This delivery order is non-set-aside and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The pharmaceutical...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency on August 20, 2025, for Trulicity 0.75 mg/0.5 ml pens valued at $4,850.62. This is a firm fixed-price, non-set-aside contract with an ultimate completion date of August 21, 2025, and performance will occur at the vendor's Conshohocken facility. The award represents a child contract executed under AmerisourceBergen's larger...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, has been awarded a delivery order by the Defense Logistics Agency (DLA) for Trulicity 1.5 mg/0.5 ml pens with a ceiling value of $3,877.77. The delivery order, issued on September 5, 2025, with an ultimate completion date of September 8, 2025, is structured as a firm fixed price contract with no set-aside designation. This award represents a competitive procurement action under the...
- The Defense Logistics Agency awarded a delivery order valued at $4,239.60 to AmerisourceBergen Drug Corp for the supply of Trulicity 1.5 mg/0.5 mL pens on September 9, 2025, with completion expected by September 10, 2025. This is a firm fixed price, non-set-aside contract with performance based in Conshohocken, Pennsylvania. The delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at...
- The Defense Logistics Agency awarded a delivery order valued at $1,949.85 to AmerisourceBergen Drug Corp for the supply of Trulicity 1.5 mg/0.5 ml pens (0.5 ml units), a diabetes medication. This competitively awarded, firm fixed-price delivery order was issued on August 27, 2025, with an ultimate completion date of August 28, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The contract represents a child order under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,351.35 to AmerisourceBergen Drug Corp for the supply of Trulicity 1.5 mg/0.5 mL pens on August 18, 2025, with completion targeted for August 19, 2025. This delivery order represents a firm fixed-price contract with no set-aside designation, issued under a competitive procurement process. The award is being fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company serves as...
- The Defense Logistics Agency awarded a $3,717.85 firm fixed-price delivery order to AmerisourceBergen Drug Corp on October 31, 2025, for the supply of Trulicity 1.5 mg/0.5 ml pens (0.5 ml units), with completion targeted for November 3, 2025. This non-set-aside contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.99 billion global pharmaceutical support vehicle running through December 2026. The...
- The Defense Logistics Agency awarded a delivery order valued at $4,209.28 to AmerisourceBergen Drug Corp for the supply of Trulicity 1.5 mg/0.5 mL pens on October 24, 2025, with an ultimate completion date of October 27, 2025. This firm fixed price delivery order was competitively awarded with no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The order represents a child contract under AmerisourceBergen's larger...
- SPE2DR25D1106Indefinite Delivery Contract
- SPE2DR25D1106-SPE2DR26FHY7DDelivery Order
The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a $23,260.35 delivery order on November 4, 2025, for the supply of Trulicity 1.5 mg/0.5 mL pens (0.5 mL units), a diabetes management medication. This is a firm fixed-price, non-set-aside contract with performance through November 5, 2025, and fulfillment from the contractor's Conshohocken, Pennsylvania location. The award represents a child delivery order under AmerisourceBergen's broader Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999,999,999 global pharmaceutical support vehicle running through December 2026. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, maintains an extensive federal contract portfolio with the Defense Logistics Agency covering a comprehensive range of pharmaceutical products and medical supplies to support military and veteran healthcare systems. This delivery order exemplifies the company's role as a critical vendor in the federal medical supply chain, fulfilling specialized pharmaceutical needs through competitively awarded contracts. The underlying IDC vehicle enables AmerisourceBergen to supply medications, vaccines, and medical devices across multiple therapeutic domains to support the Defense Health Agency, U.S. Coast Guard, and other government healthcare organizations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $23.3k | 11/4/25 |